Results 221 to 230 of about 214,460 (382)
Itch in Primary Biliary Cirrhosis: A Patients’ Perspective
E Rishe, Ali Azarm, NV Bergasa
openalex +1 more source
Cellular Mechanism and Key Insights in Allergen Immunotherapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) arises from immune responses mediated by immunoglobulin E (IgE) to inhaled allergens, representing one of the most prevalent chronic conditions worldwide. Although AR may not be a serious ailment, it holds clinical relevance as it underpins numerous complications, serves as a major risk factor for suboptimal asthma ...
Zhe Wang +3 more
wiley +1 more source
Bullous Wells' Syndrome: Case Report and Systematic Review. [PDF]
Ciccarese G +11 more
europepmc +1 more source
The alpha and beta diversity of the nasal microbiome differed among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls (HCs). Compared to HC, AR had more Escherichia‐Shigella, Negativicoccus, and Campylobacter, while NAR had more Dolosigranulum and fewer Enterobacteriaceae.
Kantima Kanchanapoomi +6 more
wiley +1 more source
Glycemic Gravity: The Pull of HbA1c on Balanoposthitis Severity. [PDF]
Sharma S +4 more
europepmc +1 more source
Development of the Infidelity Tendency Comprehensive (ITCh) Scale
Raven Kyle Gonzaga +5 more
openalex +2 more sources
DOES EPIDURAL NALOXONE ALLEVIATE ITCHING FROM INTRATHECAL FENTANYL IN THE LABORING PARTURIENT? [PDF]
Kee-Ryong Choi +3 more
openalex +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source

